Algorithm foundations with ML focus
Master core algorithms plus ML-specific problems like feature engineering, data processing pipelines, and optimization challenges.
1 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
ML engineering interviews blend algorithms, system design, and domain expertise.. Explore key insights and preparation tips to help you excel in your interview process.
Master core algorithms plus ML-specific problems like feature engineering, data processing pipelines, and optimization challenges.
Design scalable ML pipelines, real-time inference systems, and data processing architectures that handle production ML workloads.
Training Pipelines
Distributed training & model versioning
Inference Systems
Real-time prediction & batch processing
Data Architecture
Feature stores & streaming pipelines
Different companies emphasize different aspects of ML engineering based on their core products and scale challenges.
Meta
Recommendation systems & large-scale feature engineering
Uber
Real-time ML & geospatial optimization algorithms
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Philadelphia offers approximately 40% lower housing costs and 35% reduced overall living expenses compared to San Francisco, allowing ML engineers to maximize their $120K-150K salaries while enjoying urban amenities and a thriving tech ecosystem.
Philadelphia's ML job market shows significantly lower saturation than major tech hubs, creating better opportunities for career advancement and competitive positioning.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsVerismo Therapeutics is a clinical-stage cell therapy company developing a multi-chain KIR-CAR platform that adapts NK-cell killer immunoglobulin-like receptor and DAP12 signaling to extend CAR T cell therapy beyond blood cancers into solid tumors. Founded by inventors of the Kymriah CAR-T (including Carl June), the company is advancing two Phase 1 programs: SynKIR-110 in mesothelin-positive solid tumors and SynKIR-310 in relapsed/refractory B cell non-Hodgkin lymphoma. It is a U.S. subsidiary of KOSDAQ-listed HLB Innovation.
Raised
$28M
Series B · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Philadelphia, Pennsylvania
United States
Philadelphia-based healthcare technology company providing AI-driven automation for prior authorization. The platform stitches together the healthcare ecosystem by empowering providers and health systems to navigate the prior authorization process more efficiently, reducing administrative burden and accelerating patient access to care.
Raised
$8.5M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Philadelphia , Pennsylvania
United States